What do we know about the Shingrix Vaccine?
This vaccine is recommended for patients over the age of 50 years. It is a live attenuated vaccine. It is a
recombinant vaccine containing the glycoprotein E named RZV or Shingrix. Two doses are
required 2-6 months apart and can be safely given with influenza (flu) vaccine. History of chickenpox or varicella zoster doesn’t determine whether to give the vaccine or not because antibodies gained through the infection wanes with time.